ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,956, issued on April 15, was assigned to EpiVax Inc. (Providence, R.I.) and Food and Drug Administration (Silver Spring, Md.).
"Regulatory T cell epitopes" was invented by William Martin (Providence, R.I.) and Amy S. Rosenberg (Silver Spring, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present is directed to compositions comprising regulatory T cell epitopes, wherein said epitopes comprise a polypeptide comprising at least a portion of SEQ NOS: 1-14, fragments and/or variants thereof, as well as methods of producing and using the same."
The patent was filed on Aug. 23, 2022, under Application No. 17/893,579.
*For further information, inc...